SrasV1, PubMed, Curation, bibRecord, 002753

Development of antiviral therapy for severe acute respiratory syndrome.

Identifieur interne : 002753 ( PubMed/Curation ); précédent : 002752; suivant : 002754

Development of antiviral therapy for severe acute respiratory syndrome.

Auteurs : Jindrich Cinatl [Allemagne] ; Martin Michaelis ; Gerold Hoever ; Wolfgang Preiser ; Hans Wilhelm Doerr

Source :

Antiviral research [ 0166-3542 ] ; 2005.

RBID : pubmed:15878786

Descripteurs français

KwdFr :
- Animaux, Antiviraux (usage thérapeutique), Conception de médicament, Flambées de maladies, Humains, Infections à coronavirus (), Infections à coronavirus (traitement médicamenteux), Infections à coronavirus (transmission), Infections à coronavirus (épidémiologie), Syndrome respiratoire aigu sévère (), Syndrome respiratoire aigu sévère (traitement médicamenteux), Syndrome respiratoire aigu sévère (transmission), Syndrome respiratoire aigu sévère (épidémiologie), Vaccins antiviraux (immunologie), Virus du SRAS (), Virus du SRAS (immunologie).
MESH :
- immunologie : Vaccins antiviraux, Virus du SRAS.
- traitement médicamenteux : Infections à coronavirus, Syndrome respiratoire aigu sévère.
- usage thérapeutique : Antiviraux, Infections à coronavirus, Syndrome respiratoire aigu sévère.
- épidémiologie : Infections à coronavirus, Syndrome respiratoire aigu sévère.
- Animaux, Conception de médicament, Flambées de maladies, Humains, Infections à coronavirus, Syndrome respiratoire aigu sévère, Virus du SRAS.

English descriptors

KwdEn :
- Animals, Antiviral Agents (therapeutic use), Coronavirus Infections (drug therapy), Coronavirus Infections (epidemiology), Coronavirus Infections (prevention & control), Coronavirus Infections (transmission), Disease Outbreaks, Drug Design, Humans, SARS Virus (drug effects), SARS Virus (immunology), Severe Acute Respiratory Syndrome (drug therapy), Severe Acute Respiratory Syndrome (epidemiology), Severe Acute Respiratory Syndrome (prevention & control), Severe Acute Respiratory Syndrome (transmission), Viral Vaccines (immunology).
MESH :
- chemical , immunology : Viral Vaccines.
- chemical , therapeutic use : Antiviral Agents.
- drug effects : SARS Virus.
- drug therapy : Coronavirus Infections, Severe Acute Respiratory Syndrome.
- epidemiology : Coronavirus Infections, Severe Acute Respiratory Syndrome.
- immunology : SARS Virus.
- prevention & control : Coronavirus Infections, Severe Acute Respiratory Syndrome.
- transmission : Coronavirus Infections, Severe Acute Respiratory Syndrome.
- Animals, Disease Outbreaks, Drug Design, Humans.

Abstract

A new disease, the severe acute respiratory distress syndrome (SARS), caused by the SARS coronavirus (SARS-CoV), emerged at the beginning of 2003 and rapidly spread throughout the world. Although the disease had disappeared in June 2003 its re-emergence cannot be excluded. The development of vaccines against SARS-CoV may take years. Therefore, the availability of effective antiviral drugs against SARS-CoV may be crucial for the control of future SARS outbreaks. In this review, experimental and clinical data about potential anti-SARS drugs is summarised and discussed. Animal model studies will be needed to help to determine which interventions warrant controlled clinical testing.

DOI: 10.1016/j.antiviral.2005.03.002
PubMed: 15878786

Links toward previous steps (curation, corpus...)

to stream PubMed, to step Corpus: Pour aller vers cette notice dans l'étape Curation :002753

Links to Exploration step

pubmed:15878786

Le document en format XML

<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Development of antiviral therapy for severe acute respiratory syndrome.</title>
<author><name sortKey="Cinatl, Jindrich" sort="Cinatl, Jindrich" uniqKey="Cinatl J" first="Jindrich" last="Cinatl">Jindrich Cinatl</name>
<affiliation wicri:level="1"><nlm:affiliation>Institut für Medizinische Virologie, Klinikum der Johann Wolfgang Goethe-Universität, Paul Ehrlich-Str. 40, 60596 Frankfurt am Main, Germany. Cinatl@em.uni-frankfurt.de</nlm:affiliation>
<country xml:lang="fr">Allemagne</country>
<wicri:regionArea>Institut für Medizinische Virologie, Klinikum der Johann Wolfgang Goethe-Universität, Paul Ehrlich-Str. 40, 60596 Frankfurt am Main</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Michaelis, Martin" sort="Michaelis, Martin" uniqKey="Michaelis M" first="Martin" last="Michaelis">Martin Michaelis</name>
</author>
<author><name sortKey="Hoever, Gerold" sort="Hoever, Gerold" uniqKey="Hoever G" first="Gerold" last="Hoever">Gerold Hoever</name>
</author>
<author><name sortKey="Preiser, Wolfgang" sort="Preiser, Wolfgang" uniqKey="Preiser W" first="Wolfgang" last="Preiser">Wolfgang Preiser</name>
</author>
<author><name sortKey="Doerr, Hans Wilhelm" sort="Doerr, Hans Wilhelm" uniqKey="Doerr H" first="Hans Wilhelm" last="Doerr">Hans Wilhelm Doerr</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2005">2005</date>
<idno type="RBID">pubmed:15878786</idno>
<idno type="pmid">15878786</idno>
<idno type="doi">10.1016/j.antiviral.2005.03.002</idno>
<idno type="wicri:Area/PubMed/Corpus">002753</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">002753</idno>
<idno type="wicri:Area/PubMed/Curation">002753</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">002753</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">Development of antiviral therapy for severe acute respiratory syndrome.</title>
<author><name sortKey="Cinatl, Jindrich" sort="Cinatl, Jindrich" uniqKey="Cinatl J" first="Jindrich" last="Cinatl">Jindrich Cinatl</name>
<affiliation wicri:level="1"><nlm:affiliation>Institut für Medizinische Virologie, Klinikum der Johann Wolfgang Goethe-Universität, Paul Ehrlich-Str. 40, 60596 Frankfurt am Main, Germany. Cinatl@em.uni-frankfurt.de</nlm:affiliation>
<country xml:lang="fr">Allemagne</country>
<wicri:regionArea>Institut für Medizinische Virologie, Klinikum der Johann Wolfgang Goethe-Universität, Paul Ehrlich-Str. 40, 60596 Frankfurt am Main</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Michaelis, Martin" sort="Michaelis, Martin" uniqKey="Michaelis M" first="Martin" last="Michaelis">Martin Michaelis</name>
</author>
<author><name sortKey="Hoever, Gerold" sort="Hoever, Gerold" uniqKey="Hoever G" first="Gerold" last="Hoever">Gerold Hoever</name>
</author>
<author><name sortKey="Preiser, Wolfgang" sort="Preiser, Wolfgang" uniqKey="Preiser W" first="Wolfgang" last="Preiser">Wolfgang Preiser</name>
</author>
<author><name sortKey="Doerr, Hans Wilhelm" sort="Doerr, Hans Wilhelm" uniqKey="Doerr H" first="Hans Wilhelm" last="Doerr">Hans Wilhelm Doerr</name>
</author>
</analytic>
<series><title level="j">Antiviral research</title>
<idno type="ISSN">0166-3542</idno>
<imprint><date when="2005" type="published">2005</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Animals</term>
<term>Antiviral Agents (therapeutic use)</term>
<term>Coronavirus Infections (drug therapy)</term>
<term>Coronavirus Infections (epidemiology)</term>
<term>Coronavirus Infections (prevention & control)</term>
<term>Coronavirus Infections (transmission)</term>
<term>Disease Outbreaks</term>
<term>Drug Design</term>
<term>Humans</term>
<term>SARS Virus (drug effects)</term>
<term>SARS Virus (immunology)</term>
<term>Severe Acute Respiratory Syndrome (drug therapy)</term>
<term>Severe Acute Respiratory Syndrome (epidemiology)</term>
<term>Severe Acute Respiratory Syndrome (prevention & control)</term>
<term>Severe Acute Respiratory Syndrome (transmission)</term>
<term>Viral Vaccines (immunology)</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr"><term>Animaux</term>
<term>Antiviraux (usage thérapeutique)</term>
<term>Conception de médicament</term>
<term>Flambées de maladies</term>
<term>Humains</term>
<term>Infections à coronavirus ()</term>
<term>Infections à coronavirus (traitement médicamenteux)</term>
<term>Infections à coronavirus (transmission)</term>
<term>Infections à coronavirus (épidémiologie)</term>
<term>Syndrome respiratoire aigu sévère ()</term>
<term>Syndrome respiratoire aigu sévère (traitement médicamenteux)</term>
<term>Syndrome respiratoire aigu sévère (transmission)</term>
<term>Syndrome respiratoire aigu sévère (épidémiologie)</term>
<term>Vaccins antiviraux (immunologie)</term>
<term>Virus du SRAS ()</term>
<term>Virus du SRAS (immunologie)</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="immunology" xml:lang="en"><term>Viral Vaccines</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en"><term>Antiviral Agents</term>
</keywords>
<keywords scheme="MESH" qualifier="drug effects" xml:lang="en"><term>SARS Virus</term>
</keywords>
<keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>Coronavirus Infections</term>
<term>Severe Acute Respiratory Syndrome</term>
</keywords>
<keywords scheme="MESH" qualifier="epidemiology" xml:lang="en"><term>Coronavirus Infections</term>
<term>Severe Acute Respiratory Syndrome</term>
</keywords>
<keywords scheme="MESH" qualifier="immunologie" xml:lang="fr"><term>Vaccins antiviraux</term>
<term>Virus du SRAS</term>
</keywords>
<keywords scheme="MESH" qualifier="immunology" xml:lang="en"><term>SARS Virus</term>
</keywords>
<keywords scheme="MESH" qualifier="prevention & control" xml:lang="en"><term>Coronavirus Infections</term>
<term>Severe Acute Respiratory Syndrome</term>
</keywords>
<keywords scheme="MESH" qualifier="traitement médicamenteux" xml:lang="fr"><term>Infections à coronavirus</term>
<term>Syndrome respiratoire aigu sévère</term>
</keywords>
<keywords scheme="MESH" qualifier="transmission" xml:lang="en"><term>Coronavirus Infections</term>
<term>Severe Acute Respiratory Syndrome</term>
</keywords>
<keywords scheme="MESH" qualifier="usage thérapeutique" xml:lang="fr"><term>Antiviraux</term>
<term>Infections à coronavirus</term>
<term>Syndrome respiratoire aigu sévère</term>
</keywords>
<keywords scheme="MESH" qualifier="épidémiologie" xml:lang="fr"><term>Infections à coronavirus</term>
<term>Syndrome respiratoire aigu sévère</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Animals</term>
<term>Disease Outbreaks</term>
<term>Drug Design</term>
<term>Humans</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr"><term>Animaux</term>
<term>Conception de médicament</term>
<term>Flambées de maladies</term>
<term>Humains</term>
<term>Infections à coronavirus</term>
<term>Syndrome respiratoire aigu sévère</term>
<term>Virus du SRAS</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">A new disease, the severe acute respiratory distress syndrome (SARS), caused by the SARS coronavirus (SARS-CoV), emerged at the beginning of 2003 and rapidly spread throughout the world. Although the disease had disappeared in June 2003 its re-emergence cannot be excluded. The development of vaccines against SARS-CoV may take years. Therefore, the availability of effective antiviral drugs against SARS-CoV may be crucial for the control of future SARS outbreaks. In this review, experimental and clinical data about potential anti-SARS drugs is summarised and discussed. Animal model studies will be needed to help to determine which interventions warrant controlled clinical testing.</div>
</front>
</TEI>
<pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">15878786</PMID>
<DateCompleted><Year>2005</Year>
<Month>09</Month>
<Day>19</Day>
</DateCompleted>
<DateRevised><Year>2020</Year>
<Month>04</Month>
<Day>09</Day>
</DateRevised>
<Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Print">0166-3542</ISSN>
<JournalIssue CitedMedium="Print"><Volume>66</Volume>
<Issue>2-3</Issue>
<PubDate><Year>2005</Year>
<Month>Jun</Month>
</PubDate>
</JournalIssue>
<Title>Antiviral research</Title>
<ISOAbbreviation>Antiviral Res.</ISOAbbreviation>
</Journal>
<ArticleTitle>Development of antiviral therapy for severe acute respiratory syndrome.</ArticleTitle>
<Pagination><MedlinePgn>81-97</MedlinePgn>
</Pagination>
<Abstract><AbstractText>A new disease, the severe acute respiratory distress syndrome (SARS), caused by the SARS coronavirus (SARS-CoV), emerged at the beginning of 2003 and rapidly spread throughout the world. Although the disease had disappeared in June 2003 its re-emergence cannot be excluded. The development of vaccines against SARS-CoV may take years. Therefore, the availability of effective antiviral drugs against SARS-CoV may be crucial for the control of future SARS outbreaks. In this review, experimental and clinical data about potential anti-SARS drugs is summarised and discussed. Animal model studies will be needed to help to determine which interventions warrant controlled clinical testing.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Cinatl</LastName>
<ForeName>Jindrich</ForeName>
<Initials>J</Initials>
<Suffix>Jr</Suffix>
<AffiliationInfo><Affiliation>Institut für Medizinische Virologie, Klinikum der Johann Wolfgang Goethe-Universität, Paul Ehrlich-Str. 40, 60596 Frankfurt am Main, Germany. Cinatl@em.uni-frankfurt.de</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Michaelis</LastName>
<ForeName>Martin</ForeName>
<Initials>M</Initials>
</Author>
<Author ValidYN="Y"><LastName>Hoever</LastName>
<ForeName>Gerold</ForeName>
<Initials>G</Initials>
</Author>
<Author ValidYN="Y"><LastName>Preiser</LastName>
<ForeName>Wolfgang</ForeName>
<Initials>W</Initials>
</Author>
<Author ValidYN="Y"><LastName>Doerr</LastName>
<ForeName>Hans Wilhelm</ForeName>
<Initials>HW</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D016454">Review</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic"><Year>2005</Year>
<Month>04</Month>
<Day>26</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo><Country>Netherlands</Country>
<MedlineTA>Antiviral Res</MedlineTA>
<NlmUniqueID>8109699</NlmUniqueID>
<ISSNLinking>0166-3542</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList><Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D000998">Antiviral Agents</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D014765">Viral Vaccines</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D000998" MajorTopicYN="N">Antiviral Agents</DescriptorName>
<QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D018352" MajorTopicYN="N">Coronavirus Infections</DescriptorName>
<QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName>
<QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
<QualifierName UI="Q000517" MajorTopicYN="N">prevention & control</QualifierName>
<QualifierName UI="Q000635" MajorTopicYN="N">transmission</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D004196" MajorTopicYN="Y">Disease Outbreaks</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D015195" MajorTopicYN="N">Drug Design</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D045473" MajorTopicYN="N">SARS Virus</DescriptorName>
<QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName>
<QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D045169" MajorTopicYN="N">Severe Acute Respiratory Syndrome</DescriptorName>
<QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName>
<QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
<QualifierName UI="Q000517" MajorTopicYN="N">prevention & control</QualifierName>
<QualifierName UI="Q000635" MajorTopicYN="N">transmission</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D014765" MajorTopicYN="N">Viral Vaccines</DescriptorName>
<QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName>
</MeshHeading>
</MeshHeadingList>
<NumberOfReferences>198</NumberOfReferences>
</MedlineCitation>
<PubmedData><History><PubMedPubDate PubStatus="received"><Year>2005</Year>
<Month>02</Month>
<Day>15</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="revised"><Year>2005</Year>
<Month>03</Month>
<Day>16</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="accepted"><Year>2005</Year>
<Month>03</Month>
<Day>17</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed"><Year>2005</Year>
<Month>5</Month>
<Day>10</Day>
<Hour>9</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline"><Year>2005</Year>
<Month>9</Month>
<Day>20</Day>
<Hour>9</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez"><Year>2005</Year>
<Month>5</Month>
<Day>10</Day>
<Hour>9</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList><ArticleId IdType="pubmed">15878786</ArticleId>
<ArticleId IdType="pii">S0166-3542(05)00072-0</ArticleId>
<ArticleId IdType="doi">10.1016/j.antiviral.2005.03.002</ArticleId>
<ArticleId IdType="pmc">PMC7132397</ArticleId>
</ArticleIdList>
<ReferenceList><Reference><Citation>J Exp Med. 1997 May 5;185(9):1533-40</Citation>
<ArticleIdList><ArticleId IdType="pubmed">9151890</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>N Engl J Med. 2003 May 15;348(20):1977-85</Citation>
<ArticleIdList><ArticleId IdType="pubmed">12671062</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>J Virol. 2005 Feb;79(3):1966-9</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15650225</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Hong Kong Med J. 2003 Dec;9(6):399-406</Citation>
<ArticleIdList><ArticleId IdType="pubmed">14660806</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Nat Rev Microbiol. 2003 Dec;1(3):209-18</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15035025</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>FEBS Lett. 2004 Feb 27;560(1-3):141-6</Citation>
<ArticleIdList><ArticleId IdType="pubmed">14988013</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Lancet. 2003 Jul 26;362(9380):263-70</Citation>
<ArticleIdList><ArticleId IdType="pubmed">12892955</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>JAMA. 2003 Dec 24;290(24):3222-8</Citation>
<ArticleIdList><ArticleId IdType="pubmed">14693875</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>J Clin Virol. 2004 Dec;31(4):304-9</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15494274</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>J Virol. 2005 Feb;79(3):1943-7</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15650220</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>N Engl J Med. 2003 May 15;348(20):1953-66</Citation>
<ArticleIdList><ArticleId IdType="pubmed">12690092</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>J Virol. 2004 Sep;78(17):9007-15</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15308697</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Pediatrics. 1997 Mar;99(3):454-61</Citation>
<ArticleIdList><ArticleId IdType="pubmed">9041304</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>JAMA. 2003 Jun 4;289(21):2801-9</Citation>
<ArticleIdList><ArticleId IdType="pubmed">12734147</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Lancet. 2004 Jun 26;363(9427):2139-41</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15220038</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Proc Natl Acad Sci U S A. 1996 Mar 19;93(6):2448-53</Citation>
<ArticleIdList><ArticleId IdType="pubmed">8637894</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Proc Natl Acad Sci U S A. 2004 Jun 1;101(22):8455-60</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15150417</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Lancet. 2004 Jun 26;363(9427):2122-7</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15220033</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>J Virol. 1998 Sep;72(9):7084-90</Citation>
<ArticleIdList><ArticleId IdType="pubmed">9696801</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Bioorg Med Chem. 2004 May 15;12(10):2517-21</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15110833</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Avian Pathol. 2003 Dec;32(6):567-82</Citation>
<ArticleIdList><ArticleId IdType="pubmed">14676007</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Int J Mol Med. 2005 Feb;15(2):323-7</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15647850</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Thorax. 2004 May;59(5):414-20</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15115870</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Proc Natl Acad Sci U S A. 2004 Jun 8;101(23):8682-6</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15173583</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Eur J Clin Microbiol Infect Dis. 2005 Jan;24(1):44-6</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15616839</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>CMAJ. 2003 Jun 24;168(13):1649-60</Citation>
<ArticleIdList><ArticleId IdType="pubmed">12821618</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Antiviral Res. 2003 Jun;59(1):41-7</Citation>
<ArticleIdList><ArticleId IdType="pubmed">12834859</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>J Interferon Cytokine Res. 2001 Dec;21(12):1071-7</Citation>
<ArticleIdList><ArticleId IdType="pubmed">11798465</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Nat Med. 2005 Jan;11(1):56-62</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15619625</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Antivir Chem Chemother. 2003 May;14(3):145-52</Citation>
<ArticleIdList><ArticleId IdType="pubmed">14521331</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Drugs. 2000 Dec;60(6):1371-9; discussion 1380-1</Citation>
<ArticleIdList><ArticleId IdType="pubmed">11152017</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Biochem Biophys Res Commun. 1996 Oct 3;227(1):102-9</Citation>
<ArticleIdList><ArticleId IdType="pubmed">8858110</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Prog Drug Res. 2002;59:41-69</Citation>
<ArticleIdList><ArticleId IdType="pubmed">12458963</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Antiviral Res. 1987 Sep;8(2):85-95</Citation>
<ArticleIdList><ArticleId IdType="pubmed">2830846</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>J Virol. 2001 Jan;75(1):351-61</Citation>
<ArticleIdList><ArticleId IdType="pubmed">11119604</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Virology. 2001 Jan 20;279(2):371-4</Citation>
<ArticleIdList><ArticleId IdType="pubmed">11162792</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>J Biol Chem. 2004 Jan 16;279(3):1637-42</Citation>
<ArticleIdList><ArticleId IdType="pubmed">14561748</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Biochem Biophys Res Commun. 2004 Aug 6;320(4):1199-203</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15249217</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>J Clin Virol. 2004 Jan;29(1):13-22</Citation>
<ArticleIdList><ArticleId IdType="pubmed">14675864</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Nature. 1979 Oct 25;281(5733):689-90</Citation>
<ArticleIdList><ArticleId IdType="pubmed">233133</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Nat Rev Immunol. 2002 Sep;2(9):675-87</Citation>
<ArticleIdList><ArticleId IdType="pubmed">12209136</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Lancet. 2003 May 24;361(9371):1767-72</Citation>
<ArticleIdList><ArticleId IdType="pubmed">12781535</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Antimicrob Agents Chemother. 2004 Oct;48(10):4006-8</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15388466</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>J Virol. 2005 Feb;79(3):1635-44</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15650189</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Clin Infect Dis. 2003 Oct 15;37(8):1139-42</Citation>
<ArticleIdList><ArticleId IdType="pubmed">14523782</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Antiviral Res. 2004 Apr;62(1):27-36</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15026199</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Nature. 2003 Nov 27;426(6965):450-4</Citation>
<ArticleIdList><ArticleId IdType="pubmed">14647384</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Crit Care Med. 2002 Oct;30(10):2284-94</Citation>
<ArticleIdList><ArticleId IdType="pubmed">12394957</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Curr Opin Infect Dis. 2001 Dec;14(6):757-64</Citation>
<ArticleIdList><ArticleId IdType="pubmed">11964896</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>J Med Virol. 2003 Feb;69(2):188-94</Citation>
<ArticleIdList><ArticleId IdType="pubmed">12683406</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>CMAJ. 2003 May 27;168(11):1415-20</Citation>
<ArticleIdList><ArticleId IdType="pubmed">12771070</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Int Immunopharmacol. 2005 Mar;5(3):571-80</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15683852</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Expert Opin Biol Ther. 2004 Jun;4(6):827-36</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15174965</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Ann N Y Acad Sci. 1977 Mar 4;284:239-46</Citation>
<ArticleIdList><ArticleId IdType="pubmed">212975</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Lancet. 2003 Jul 26;362(9380):293-4</Citation>
<ArticleIdList><ArticleId IdType="pubmed">12892961</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Expert Opin Pharmacother. 2004 Aug;5(8):1687-93</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15264983</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>J Infect Chemother. 2004 Feb;10(1):1-7</Citation>
<ArticleIdList><ArticleId IdType="pubmed">14991510</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Virology. 2004 Nov 10;329(1):11-7</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15476870</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Proc Natl Acad Sci U S A. 2004 Nov 2;101(44):15748-53</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15496474</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Clin Infect Dis. 2004 Apr 1;38(7):1030-2</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15034838</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>J Virol. 2004 Oct;78(20):11334-9</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15452254</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Proc Natl Acad Sci U S A. 2004 Jul 6;101(27):10012-7</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15226499</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>N Engl J Med. 2003 May 15;348(20):1967-76</Citation>
<ArticleIdList><ArticleId IdType="pubmed">12690091</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Lancet. 2004 Jun 26;363(9427):2102-3</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15220029</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Thorax. 2004 Mar;59(3):252-6</Citation>
<ArticleIdList><ArticleId IdType="pubmed">14985565</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>J Infect Dis. 1986 Sep;154(3):443-7</Citation>
<ArticleIdList><ArticleId IdType="pubmed">3016111</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Proc Natl Acad Sci U S A. 2004 Jun 29;101(26):9804-9</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15210961</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>J Acquir Immune Defic Syndr. 2003 Oct 1;34(2):242-3</Citation>
<ArticleIdList><ArticleId IdType="pubmed">14526215</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Antivir Chem Chemother. 2001 Mar;12(2):125-31</Citation>
<ArticleIdList><ArticleId IdType="pubmed">11527044</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Arch Pathol Lab Med. 2004 Dec;128(12):1346-50</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15578877</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Semin Liver Dis. 2004;24 Suppl 2:97-104</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15346252</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Emerg Infect Dis. 2004 Feb;10(2):317-9</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15030704</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>J Infect Dis. 2005 Feb 15;191(4):507-14</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15655773</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Trends Mol Med. 2004 Feb;10(2):47-51</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15106614</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Can J Vet Res. 1991 Apr;55(2):143-9</Citation>
<ArticleIdList><ArticleId IdType="pubmed">1653103</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Cancer Lett. 1990 Jan;49(1):9-12</Citation>
<ArticleIdList><ArticleId IdType="pubmed">2302700</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Brain Res Brain Res Rev. 2003 May;42(2):169-85</Citation>
<ArticleIdList><ArticleId IdType="pubmed">12738057</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Biochemistry. 2004 May 4;43(17):4906-12</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15109248</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Proc Natl Acad Sci U S A. 2004 Jun 8;101(23):8676-81</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15173599</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>World J Gastroenterol. 2004 Dec 1;10(23):3500-5</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15526373</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>JAMA. 2003 Nov 26;290(20):2665-6</Citation>
<ArticleIdList><ArticleId IdType="pubmed">14645307</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>J Virol. 2005 Feb;79(4):2079-86</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15681410</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Pathobiology. 2002-2003;70(4):229-36</Citation>
<ArticleIdList><ArticleId IdType="pubmed">12679601</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Nat Med. 2005 Jan;11(1):50-5</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15619632</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>J Virol. 1999 Jan;73(1):695-701</Citation>
<ArticleIdList><ArticleId IdType="pubmed">9847375</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>J Gastroenterol Hepatol. 2002 Nov;17(11):1198-204</Citation>
<ArticleIdList><ArticleId IdType="pubmed">12453280</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Rev Med Virol. 2003 Nov-Dec;13(6):361-71</Citation>
<ArticleIdList><ArticleId IdType="pubmed">14625884</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Proc Natl Acad Sci U S A. 2005 Jan 18;102(3):797-801</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15642942</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>J Virol. 2004 Dec;78(24):14043-7</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15564512</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>J Virol. 1997 Mar;71(3):2202-10</Citation>
<ArticleIdList><ArticleId IdType="pubmed">9032354</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Clin Ther. 1999 Dec;21(12):2080-90</Citation>
<ArticleIdList><ArticleId IdType="pubmed">10645755</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>CMAJ. 2004 Nov 23;171(11):1349-52</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15557587</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Virology. 1999 Jun 5;258(2):435-40</Citation>
<ArticleIdList><ArticleId IdType="pubmed">10366581</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Clin Microbiol Infect. 2004 Jul;10(7):676-8</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15214887</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Biochem Biophys Res Commun. 2003 Oct 10;310(1):78-83</Citation>
<ArticleIdList><ArticleId IdType="pubmed">14511651</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>J Virol. 2004 Nov;78(22):12672-6</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15507655</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>J Med Microbiol. 2003 Aug;52(Pt 8):715-720</Citation>
<ArticleIdList><ArticleId IdType="pubmed">12867568</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Am J Chin Med. 1996;24(3-4):271-8</Citation>
<ArticleIdList><ArticleId IdType="pubmed">8982439</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Chin Med J (Engl). 2003 Aug;116(8):1262-4</Citation>
<ArticleIdList><ArticleId IdType="pubmed">12935424</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Science. 1972 Aug 25;177(4050):705-6</Citation>
<ArticleIdList><ArticleId IdType="pubmed">4340949</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Hypertension. 2004 Dec;44(6):903-6</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15492138</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Nat Med. 2004 Aug;10(8):871-5</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15247913</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Science. 2003 Jun 13;300(5626):1763-7</Citation>
<ArticleIdList><ArticleId IdType="pubmed">12746549</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>J Med Virol. 2004 Jul;73(3):323-31</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15170624</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Hong Kong Med J. 2003 Jun;9(3):199-201</Citation>
<ArticleIdList><ArticleId IdType="pubmed">12777656</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Scand J Infect Dis. 2004;36(11-12):829-31</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15764169</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Biochem Biophys Res Commun. 2003 Apr 11;303(3):940-6</Citation>
<ArticleIdList><ArticleId IdType="pubmed">12670502</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Science. 2004 Feb 13;303(5660):944-6</Citation>
<ArticleIdList><ArticleId IdType="pubmed">14963300</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>J Clin Pharmacol. 2004 Mar;44(3):265-75</Citation>
<ArticleIdList><ArticleId IdType="pubmed">14973309</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Antimicrob Agents Chemother. 2004 Sep;48(9):3382-9</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15328100</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>J Invest Dermatol. 2005 Feb;124(2):405-11</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15675961</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>J Virol. 2004 Apr;78(7):3572-7</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15016880</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>J Chem Inf Model. 2005 Jan-Feb;45(1):10-17</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15667124</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Antimicrob Agents Chemother. 2004 May;48(5):1872-5</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15105147</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>J Clin Virol. 2004 Jul;30(3):211-3</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15135736</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Proc Natl Acad Sci U S A. 2003 Nov 11;100(23):13190-5</Citation>
<ArticleIdList><ArticleId IdType="pubmed">14585926</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Immunol Invest. 1995 Nov;24(6):977-86</Citation>
<ArticleIdList><ArticleId IdType="pubmed">8575842</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>J Virol. 2003 May;77(10):5933-47</Citation>
<ArticleIdList><ArticleId IdType="pubmed">12719586</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Trends Mol Med. 2004 Feb;10(2):78-84</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15102361</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Antiviral Res. 2003 Mar;58(1):73-9</Citation>
<ArticleIdList><ArticleId IdType="pubmed">12719009</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Antimicrob Agents Chemother. 2004 Jul;48(7):2693-6</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15215127</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Nat Rev Microbiol. 2004 Sep;2(9):704-20</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15372081</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Hong Kong Med J. 2003 Oct;9(5):391-2</Citation>
<ArticleIdList><ArticleId IdType="pubmed">14530539</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Antimicrob Agents Chemother. 2004 Oct;48(10):3905-11</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15388451</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Med Trop (Mars). 1990 Jan-Mar;50(1):103-8</Citation>
<ArticleIdList><ArticleId IdType="pubmed">2195275</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Lancet. 2004 Mar 20;363(9413):938-47</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15043961</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Biochem Biophys Res Commun. 2005 Jan 28;326(4):905-8</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15607755</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Biochem Pharmacol. 2002 Apr 15;63(8):1481-4</Citation>
<ArticleIdList><ArticleId IdType="pubmed">11996889</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Nature. 2003 May 15;423(6937):240</Citation>
<ArticleIdList><ArticleId IdType="pubmed">12748632</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Biochem Pharmacol. 2003 Oct 15;66(8):1505-12</Citation>
<ArticleIdList><ArticleId IdType="pubmed">14555228</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Nucleic Acids Res. 2003 Dec 15;31(24):7117-30</Citation>
<ArticleIdList><ArticleId IdType="pubmed">14654687</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>J Virol. 2004 Jul;78(14):7523-7</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15220426</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Cell Mol Life Sci. 2004 Aug;61(16):2100-12</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15316659</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Emerg Infect Dis. 2004 Apr;10(4):581-6</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15200845</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Curr Med Chem. 2003 Jan;10(2):155-71</Citation>
<ArticleIdList><ArticleId IdType="pubmed">12570715</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>AIDS. 2002 Mar 29;16(5):693-700</Citation>
<ArticleIdList><ArticleId IdType="pubmed">11964525</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Clin Infect Dis. 2004 Nov 15;39(10):1531-5</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15546092</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Lancet. 2003 Jun 14;361(9374):2045-6</Citation>
<ArticleIdList><ArticleId IdType="pubmed">12814717</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Antiviral Res. 2005 Jan;65(1):45-8</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15652970</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>J Biol Chem. 2004 Apr 23;279(17):17996-8007</Citation>
<ArticleIdList><ArticleId IdType="pubmed">14754895</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Int J Biochem Cell Biol. 2002 Jul;34(7):722-5</Citation>
<ArticleIdList><ArticleId IdType="pubmed">11950589</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Acta Pharmacol Sin. 2003 Jun;24(6):497-504</Citation>
<ArticleIdList><ArticleId IdType="pubmed">12791174</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Nature. 2003 Oct 30;425(6961):915</Citation>
<ArticleIdList><ArticleId IdType="pubmed">14586458</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Emerg Infect Dis. 2004 Mar;10(3):389-94</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15109402</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>J Med Chem. 2004 Dec 2;47(25):6113-6</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15566280</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Antivir Ther. 2004 Dec;9(6):1003-11</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15651759</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Antimicrob Agents Chemother. 1997 Mar;41(3):551-6</Citation>
<ArticleIdList><ArticleId IdType="pubmed">9055991</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Biochem Biophys Res Commun. 2004 Oct 8;323(1):264-8</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15351731</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>J Antimicrob Chemother. 2003 Jan;51(1):93-9</Citation>
<ArticleIdList><ArticleId IdType="pubmed">12493792</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>J Interferon Res. 1989 Jun;9(3):285-93</Citation>
<ArticleIdList><ArticleId IdType="pubmed">2545792</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>BMC Microbiol. 2003 Sep 21;3:20</Citation>
<ArticleIdList><ArticleId IdType="pubmed">14499001</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>J Virol. 1998 Jun;72(6):4547-51</Citation>
<ArticleIdList><ArticleId IdType="pubmed">9573217</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>J Virol. 2005 Jan;79(1):503-11</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15596843</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Cell. 2001 Apr 6;105(1):137-48</Citation>
<ArticleIdList><ArticleId IdType="pubmed">11301009</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>N Engl J Med. 2003 Dec 18;349(25):2431-41</Citation>
<ArticleIdList><ArticleId IdType="pubmed">14681510</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>J Antimicrob Chemother. 1986 Oct;18 Suppl B:153-6</Citation>
<ArticleIdList><ArticleId IdType="pubmed">3025154</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Curr Ther Res Clin Exp. 2004 Jan;65(1):26-33</Citation>
<ArticleIdList><ArticleId IdType="pubmed">24936101</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Yakugaku Zasshi. 2000 Oct;120(10):849-62</Citation>
<ArticleIdList><ArticleId IdType="pubmed">11082698</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Proc Natl Acad Sci U S A. 1998 Oct 27;95(22):13120-4</Citation>
<ArticleIdList><ArticleId IdType="pubmed">9789051</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>J Med Chem. 2005 Feb 24;48(4):1256-9</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15715493</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Nat Med. 2004 Mar;10(3):290-3</Citation>
<ArticleIdList><ArticleId IdType="pubmed">14981511</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>J Interferon Cytokine Res. 2004 Jul;24(7):388-90</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15296649</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Hong Kong Med J. 2003 Aug;9(4):309; author reply 310</Citation>
<ArticleIdList><ArticleId IdType="pubmed">12904626</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Trends Neurosci. 2000 Jan;23(1):20-6</Citation>
<ArticleIdList><ArticleId IdType="pubmed">10631785</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>J Infect Dis. 2004 Apr 1;189(7):1164-7</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15031783</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>J Biol Chem. 2003 Apr 18;278(16):14162-7</Citation>
<ArticleIdList><ArticleId IdType="pubmed">12576481</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Nat Med. 2004 Dec;10(12 Suppl):S88-97</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15577937</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>J Altern Complement Med. 2004 Dec;10(6):1041-51</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15674000</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Clin Infect Dis. 2004 Oct 1;39(7):1071-5</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15472864</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Antivir Chem Chemother. 2004 Jan;15(1):15-22</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15074711</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Emerg Infect Dis. 2004 Jan;10(1):20-4</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15078592</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Chest. 1998 Aug;114(2):452-6</Citation>
<ArticleIdList><ArticleId IdType="pubmed">9726729</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Biochim Biophys Acta. 2000 Mar 7;1477(1-2):168-88</Citation>
<ArticleIdList><ArticleId IdType="pubmed">10708857</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Emerg Infect Dis. 2003 Jun;9(6):713-7</Citation>
<ArticleIdList><ArticleId IdType="pubmed">12781012</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>J Virol. 2004 Oct;78(20):11401-4</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15452262</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Biochem Biophys Res Commun. 2004 Jun 4;318(3):719-25</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15144898</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>CMAJ. 2003 May 13;168(10):1289-92</Citation>
<ArticleIdList><ArticleId IdType="pubmed">12743076</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Lancet Infect Dis. 2002 May;2(5):273-80</Citation>
<ArticleIdList><ArticleId IdType="pubmed">12062993</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Lancet. 2003 Apr 19;361(9366):1319-25</Citation>
<ArticleIdList><ArticleId IdType="pubmed">12711465</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>J Gen Virol. 1991 Jun;72 ( Pt 6):1317-22</Citation>
<ArticleIdList><ArticleId IdType="pubmed">1646275</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>J Clin Virol. 2004 Sep;31(1):69-75</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15288617</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Proc Natl Acad Sci U S A. 2004 Feb 24;101(8):2536-41</Citation>
<ArticleIdList><ArticleId IdType="pubmed">14983044</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Lancet. 2003 May 10;361(9369):1615-7</Citation>
<ArticleIdList><ArticleId IdType="pubmed">12747883</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Emerg Infect Dis. 2004 Sep;10(9):1550-7</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15498155</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>J Immunol. 1998 Apr 1;160(7):3487-93</Citation>
<ArticleIdList><ArticleId IdType="pubmed">9531310</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>N Engl J Med. 1986 Jan 2;314(1):20-6</Citation>
<ArticleIdList><ArticleId IdType="pubmed">3940312</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Antimicrob Agents Chemother. 2004 Mar;48(3):867-72</Citation>
<ArticleIdList><ArticleId IdType="pubmed">14982777</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Antimicrob Agents Chemother. 1991 Apr;35(4):679-84</Citation>
<ArticleIdList><ArticleId IdType="pubmed">2069373</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Immunol Cell Biol. 2003 Jun;81(3):224-9</Citation>
<ArticleIdList><ArticleId IdType="pubmed">12752687</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Annu Rev Microbiol. 2001;55:255-81</Citation>
<ArticleIdList><ArticleId IdType="pubmed">11544356</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Am J Respir Crit Care Med. 2005 Mar 1;171(5):518-26</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15591472</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
</PubmedData>
</pubmed>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/SrasV1/Data/PubMed/Curation

HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 002753 | SxmlIndent | more

HfdSelect -h $EXPLOR_AREA/Data/PubMed/Curation/biblio.hfd -nk 002753 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    SrasV1
   |flux=    PubMed
   |étape=   Curation
   |type=    RBID
   |clé=     pubmed:15878786
   |texte=   Development of antiviral therapy for severe acute respiratory syndrome.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Curation/RBID.i   -Sk "pubmed:15878786" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Curation/biblio.hfd   \
       | NlmPubMed2Wicri -a SrasV1

This area was generated with Dilib version V0.6.33.
Data generation: Tue Apr 28 14:49:16 2020. Site generation: Sat Mar 27 22:06:49 2021

	Serveur d'exploration SRAS
	Attention, ce site est en cours de développement ! Attention, site généré par des moyens informatiques à partir de corpus bruts. Les informations ne sont donc pas validées.

Serveur d'exploration SRAS

Development of antiviral therapy for severe acute respiratory syndrome.

Development of antiviral therapy for severe acute respiratory syndrome.

Source :

Descripteurs français

English descriptors

Abstract

Links toward previous steps (curation, corpus...)

Links to Exploration step

Le document en format XML

Pour manipuler ce document sous Unix (Dilib)

Pour mettre un lien sur cette page dans le réseau Wicri

Pour générer des pages wiki